Business Update
Cepheid launches CE Mark-certified Smart VZV in vitro diagnostic test for SmartCycler Platform
Published in Gene Therapy Weekly, June 29th, 2006
The VZV assay was released as a CE IVD Mark product under the European Directive on In Vitro Diagnostic Medical Devices. Smart VZV is intended for rapid detection of the varicella-zoster virus, a member of the herpes virus subfamily, the cause of potentially life-threatening complications of the lungs, liver and central nervous system in immunocompromised children. The virus can also cause serious eye, kidney and brain infections also known as retinitis, acute renal necrosis and chronic progressive...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2006-06-29)
More Articles from Gene Therapy Weekly
- DNA Research
Aberrant ocular albinism gene splicing can be corrected - Immunotherapy
Immunotherapeutic potential of adenoviral-mediated gene transfer revealed - RNA Interference
Mammalian gene expression is artificially controlled by modulating RNA interference - RNA Interference
Short hairpin RNAs delivered into mouse embryonic stem cells - Respiratory Medicine
Airway inflammation is facilitated by local blockade of T-bet expression - Allergy & Immunology
T cell receptor codon modification enhances functional expression - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
